{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:00:58Z","timestamp":1781071258155,"version":"3.54.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Health Serv."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transfusion-transmitted reactions remain a significant concern in platelet transfusion medicine because of inadequate platelet inventory management (PIM) and allocation processes. Existing issuing policies lack structured, patient-centric approaches that adequately address compatibility factors and the allocation of platelet components based on specific treatment demands.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This model proposes a simulation-based, patient-centric platelet issuing policy that integrates product age preferences, ABO\/Rh factor compatibility, and the blood group subtypes of A, and prioritizes platelet product preferences. A hybrid strategy combining Fresh Unit First Use (FUFU) and Old Unit First Use (OUFU) policies ensures precise allocation. Moreover, compatible substitution enables single-donor platelets (SDP) to replace random-donor platelets (RDP) and vice versa for the heterogeneous demand. Model parameters are derived from the literature and supplemented by preliminary expert input. The proposed model was evaluated through case studies, numerical example using MATLAB, and simulation experiments using Arena.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The simulation results show improved operational performance in terms of service level, backlog reduction, and allocation efficiency across multiple demand scenarios. In particular, the conventional ABO system achieved service levels of 0% for the scenario service level of 99.9%, whereas the proposed policy achieved service levels above 50% for the same scenario, demonstrating its effectiveness in handling subtype-specific inventory management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The proposed heuristic model provides a structured, simulation-based approach for evaluating issuing policies under compatibility and demand conditions. These findings highlight the potential incorporation of subtype classification and hybrid allocation strategies to enhance the operational efficiency of platelet inventory systems. However, the results are derived from a simulation environment, and further real-world validation is required to assess clinical applicability and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Sustainability development goals 2023<\/jats:title>\n                    <jats:p>\n                      <jats:sup>3<\/jats:sup>\n                      Good health and well-being.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/frhs.2026.1813185","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:20:47Z","timestamp":1781068847000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Heuristic platelet issuing policies for an integrated ABO blood bank system under heterogeneous demand: towards patient-centric management"],"prefix":"10.3389","volume":"6","author":[{"given":"Chithraponnu","family":"R","sequence":"first","affiliation":[{"name":"Department of Mathematics, School of Advanced Sciences, Vellore Institute of Technology (VIT)","place":["Chennai, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umamaheswari","family":"S","sequence":"additional","affiliation":[{"name":"Department of Mathematics, School of Advanced Sciences, Vellore Institute of Technology (VIT)","place":["Chennai, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1182\/hematology.2020000135","article-title":"Does abo and RHD matching matter for platelet transfusion?","volume":"2020","author":"Dunbar","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/17477778.2018.1497461","article-title":"Platelet inventory management: a rolling-horizon SIM\u2013OPT approach for age-differentiated demand","volume":"13","author":"Dalalah","year":"2018","journal-title":"J Simul"},{"key":"B3","volume-title":"Raster: Geographic Analysis and Modeling With Raster Data. AABB Technical Manual","author":"Fung","year":"2014"},{"key":"B4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-3-319-47766-4_10","article-title":"Blood platelet inventory management. Markov decision processes in practice","volume":"248","author":"Haijema","year":"2017","journal-title":"Int Ser Oper Res Manag Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41568-023-00639-6","article-title":"The dynamic role of platelets in cancer progression and their therapeutic implications","volume":"24","author":"Li","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01342-w","article-title":"The critical role of platelets in cancer progression and metastasis","volume":"28","author":"Zhou","year":"2023","journal-title":"Eur J Med Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.cor.2005.03.023","article-title":"Blood platelet production: optimization by dynamic programming and simulation","volume":"34","author":"Haijema","year":"2007","journal-title":"Comput Oper Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/microorganisms12020258","article-title":"Bacterial contamination of platelet products","volume":"12","author":"Jacobs","year":"2024","journal-title":"Microorganisms"},{"key":"B9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.ejor.2015.01.023","article-title":"Blood platelet inventory management with protection levels","volume":"243","author":"Civelek","year":"2015","journal-title":"Eur J Oper Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2478\/mspe-2021-0013","article-title":"Multi-period age-discriminated perishable inventory","volume":"29","author":"Alrawabdeh","year":"2021","journal-title":"Manag Syst Prod Eng"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4184979","article-title":"Age-based platelet joint inventory optimization","author":"Zhou","year":"2022","journal-title":"SSRN Electron J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1248\/bpb.b22-00374","article-title":"Factors affecting the comprehension of outpatients receiving cancer chemotherapy","volume":"46","author":"Nishibe-Toyosato","year":"2023","journal-title":"Biol Pharm Bull"},{"key":"B13","first-page":"1","article-title":"Management of age-differentiated perishable inventory","author":"Dalalah","year":"2017"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s12652-019-01315-0","article-title":"Blood supply chain management: robust optimization, disruption risk, and blood group compatibility (a real-life case)","volume":"11","author":"Hosseini-Motlagh","year":"2019","journal-title":"J Ambient Intell Humaniz Comput"},{"key":"B15","doi-asserted-by":"publisher","first-page":"102657","DOI":"10.1016\/j.transci.2019.09.010","article-title":"Efficacy of cross-match compatible platelets in multi-transfused haemato-oncology patients refractory to platelet transfusion","volume":"58","author":"Chavanetal","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"102868","DOI":"10.1016\/j.transci.2020.102868","article-title":"Challenges in platelet inventory management at a tertiary care oncology center during the novel coronavirus disease (COVID-19) pandemic lockdown in India","volume":"59","author":"Ojha","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"B17","article-title":"Effects of single-donor platelet versus random donor platelet concentrates in thrombocytopenic patients at SKIMS blood bank-A hospital-based study","volume":"24","author":"Sabha","year":"2021","journal-title":"J Med Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/trf.15655","article-title":"ABO-incompatible platelets are associated with increased transfusion reaction rates","volume":"60","author":"Malvik","year":"2020","journal-title":"Transfusion"},{"key":"B19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00062752-200111000-00013","article-title":"Single-donor versus pooled random-donor platelet concentrates","volume":"8","author":"Ness","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000351230","article-title":"Platelet transfusion- the art and science of compromise","volume":"40","author":"Cid","year":"2013","journal-title":"Transfus Med Hemother"},{"key":"B21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/0973-6247.162684","article-title":"Current trends in platelet transfusions practice: the role of ABO-RHd and human leukocyte antigen incompatibility","volume":"9","author":"Valsami","year":"2015","journal-title":"Asian J Transfus Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1469-1809.1939.tb02222.x","article-title":"The distributions in the A1A2BO blood groups in England","volume":"9","author":"Ikin","year":"1939","journal-title":"Ann Eugen"},{"key":"B23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejmhg.2012.06.001","article-title":"Prevalence and gene frequencies of A1A2BO and Rh(D) blood group alleles among some muslim populations of north India","volume":"14","author":"Hussain","year":"2013","journal-title":"Egypt J Med Hum Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/joah.joah_15_20","article-title":"Prevalence of A2 and A2B subgroups along with anti-A1 antibody in patients and donor population and its clinical significance","volume":"11","author":"Mukherjee","year":"2020","journal-title":"J Appl Hematol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/ejh.ejh_51_20","article-title":"A1 and A2 subtypes of blood group A: a reflection of their prevalence in Fayoum university hospital blood bank","volume":"46","author":"Abdelaziz","year":"2021","journal-title":"Egypt J Haematol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/26772.9893","article-title":"A1 and A2 subtypes of blood group \u2018A\u2019: a reflection of their prevalence in the north Karnataka region","volume":"11","author":"Giriyan","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7860\/jcdr\/2014\/7987.4053","article-title":"A rare case of A2+ ve blood group in an obstetric emergency","volume":"8","author":"Bhatara","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.21833\/ijaas.2023.02.025","article-title":"Amelioration in cross-matching policy with subtypes for priority-based demand","volume":"10","author":"Chithraponnu","year":"2023","journal-title":"Int J Adv Appl Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"100843","DOI":"10.1016\/j.xkme.2024.100843","article-title":"A2\/A2B deceased donor kidney transplantation utilizing A2 titers improves access to kidney transplantation: a single center study","volume":"6","author":"Lum","year":"2024","journal-title":"Kidney Med"},{"key":"B30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/978-1-4939-1007-6_18","article-title":"\u201cInventory management in blood banks,\u201d International Series in Operations Research & Management Science","volume-title":"Studies in Operations Research, edition 127 chapter 18","author":"Lowalekar","year":"2015"},{"key":"B31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.transci.2014.01.014","article-title":"A1A2BO and Rh gene frequencies among six populations of Jammu and Kashmir, India","volume":"50","author":"Fareed","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/voxs.12576","article-title":"Distribution of ABO and Rh (D) blood groups in India: a systematic review","volume":"16","author":"Patidar","year":"2020","journal-title":"ISBT Sci Ser"},{"key":"B33","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.cardfail.2022.10.182","article-title":"Impact of blood group a subtyping on cardiac transplantation outcomes","volume":"29","author":"Kim","year":"2023","journal-title":"J Card Fail"},{"key":"B34","year":""},{"key":"B35","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1537-2995.1988.28588337336.x","article-title":"Minimal expression of blood group A antigen on thrombocytes from A2 individuals","volume":"28","author":"Skogen","year":"1988","journal-title":"Transfusion"},{"key":"B36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1182\/blood.v108.11.579.579","article-title":"Apart from blood group A2, ABO antigen-incompatible platelet transfusions result in significantly lower corrected count increments (CCI) in children","volume":"108","author":"Julmy","year":"2006","journal-title":"Blood"},{"key":"B37","first-page":"819","article-title":"Improving blood bank inventory management using double cross-match and hybrid issuance policy","author":"Bozorgi","year":"2020"},{"key":"B38","doi-asserted-by":"publisher","first-page":"103782","DOI":"10.1016\/j.transci.2023.103782","article-title":"Therapeutic plasma exchange in alloimmune platelet refractoriness","volume":"62","author":"Raza","year":"2023","journal-title":"Transfus Apher Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/ajts.ajts_66_21","article-title":"Detectionof a weaker subgroup of a in ABO blood group system","volume":"16","author":"Chopra","year":"2022","journal-title":"Asian J Transfus Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jemermed.2016.04.010","article-title":"Red blood cell transfusion in the emergency department","volume":"51","author":"Long","year":"2016","journal-title":"Emerg Med J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2240146","article-title":"Forward and reverse typing discrepancy and crossmatch incompatibility of ABO blood groups: cause analysis and treatment","volume":"28","author":"Qiu","year":"2023","journal-title":"Hematology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.14704\/nq.2022.20.10.NQ55085","article-title":"An anatomization study on oid policy in blood inventory management","volume":"20","author":"Chithraponnu","year":"2022","journal-title":"Neuroquantology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/deci.12092","article-title":"On the issuing policies for perishable items such as red blood cells and platelets in blood service","volume":"45","author":"Abbasi","year":"2014","journal-title":"Decis Sci"},{"key":"B44","article-title":"Perishable inventory systems","volume-title":"International Series in Operations Research & Management Science","author":"Nahmias","year":"2011"},{"key":"B45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/moh.0000000000000843","article-title":"Platelet transfusion","volume":"32","author":"Mo","year":"2024","journal-title":"Curr Opin Hematol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/JBM.S234374","article-title":"Platelet transfusion: an update on challenges and outcomes","volume":"11","author":"Solves Alcaina","year":"2020","journal-title":"J Blood Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.2025.7529","article-title":"Platelet transfusion: 2025 AAAB and ICTMG international clinical practice guidelines","volume":"334","author":"Metcalf","year":"2025","journal-title":"J Am Med Assoc"},{"key":"B48","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cie.2019.03.010","article-title":"Inventory management of platelets along blood supply chain to minimize wastage and shortage","volume":"130","author":"Rajendran","year":"2019","journal-title":"Comput Ind Eng"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1080\/00207543.2024.2396511","article-title":"An integrated blood supply chain network design during a pandemic","volume":"63","author":"Yang","year":"2024","journal-title":"Int J Prod Res"},{"key":"B50","author":"Palihavadana","year":""},{"key":"B51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/tme.13131","article-title":"Red blood cell inventory management: insights from transfusion laboratory technologists in British Columbia, Canada","volume":"35","author":"Dhahan","year":"2025","journal-title":"Transfus Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"306","DOI":"10.18231\/j.ijpo.2021.060","article-title":"Anti-D alloimmunization after platelet transfusion","volume":"8","author":"Shah","year":"2021","journal-title":"Indian J Pathol Oncol"},{"key":"B53","first-page":"49","article-title":"Reference design model for a patient-centric data exchange healthcare environment","author":"Khatiwada","year":"2022"},{"key":"B54","year":""},{"key":"B55","unstructured":"Stepanovs\n              J\n            \n          \n          R\u012bga Stradi\u0146\u0161 University\n          Thromboelastometry for microvascular flap thrombo sis risk assessment in trauma patients undergoing reconstructive surgery\n          \n          2025"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70058","article-title":"Disseminated intravascular coagulation: cause, molecular mechanism, diagnosis, and therapy","volume":"6","author":"Gong","year":"2025","journal-title":"MedComm"},{"key":"B57","author":"Petraszko","year":""},{"key":"B58","first-page":"260","article-title":"Some observations on genetic diversity and microdifferentiation processes among some populations of north India using ABO subtypes and Rh markers","volume":"5","author":"Ara","year":"2011","journal-title":"Adv Biol Res"}],"container-title":["Frontiers in Health Services"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frhs.2026.1813185\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:20:50Z","timestamp":1781068850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frhs.2026.1813185\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":58,"alternative-id":["10.3389\/frhs.2026.1813185"],"URL":"https:\/\/doi.org\/10.3389\/frhs.2026.1813185","relation":{},"ISSN":["2813-0146"],"issn-type":[{"value":"2813-0146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1813185"}}